Strategic partnership Recent collaboration with Evotec SE to identify targets and biomarkers in obesity and metabolic diseases signals a strong appetite for co-development and external partnerships. Leverage this by proposing joint discovery programs or licensing opportunities in metabolic health, obesity, and related biomarkers.

Translational strength Inserm Transfert specializes in value creation and technology transfer from Inserm labs to industry, with established funds for proofs of concept and pre-entrepreneurship support. Target biotech startups and mid-sized pharma seeking early-stage translational services, IP strategy, and Proof-of-Concept funding.

Robust network A history of spin-outs and collaborations (Lys Therapeutics, Tonix, Cytovia) demonstrates a proven ability to commercialize life sciences innovations. Use this network to position co-development, licensing, or sponsored research deals that leverage Inserm Transfert’s governance and funding framework.

Full service platform Offers end-to-end technology transfer services from invention disclosure to industrial partnerships and startups, plus management of national and international projects and health data domains. Sell end-to-end collaboration packages, including project setup, data handling, and regulatory alignment.

Financial potential Revenue range indicates a mid-market scale with active deal flow and funded programs via dedicated seed and PoC funds. Prioritize opportunities with milestones tied to PoC outcomes, enabling risk-sharing structures and milestone-based licensing or collaboration agreements.